Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Psychiatry Res ; 251: 319-324, 2017 May.
Article in English | MEDLINE | ID: mdl-28237910

ABSTRACT

Social cognition is impaired in schizophrenia, is relatively independent of purely neurocognitive domains such as attention and executive functioning, and may be the strongest predictor of functional outcome in this disease. Within a motivated reasoning framework, we tested the hypothesis that the anti-inflammatory Th2-associated cytokines, IL-10 and MDC, would be correlated with behavioral measures of social cognitive threat-detection bias (self-referential gaze detection bias and theory of mind (ToM) bias) in delusional versus non-delusional patients. We administered to schizophrenia patients with delusions (n=21), non-delusional patients (n=39) and controls (n=20) a social cognitive task designed to be sensitive to psychosocial stress response (the Waiting Room Task) and collected plasma levels of inflammatory markers using a bead-based flow immunoassay. Results partially supported our hypothesis. The anti-inflammatory cytokine IL-10 was associated with self-referential ToM bias in the delusional cohort as predicted, and not with non-delusional patients or healthy controls. This bias reflects a documented tendency of schizophrenia patients with delusions to excessively attribute hostile intentions to people in their environment. Since this cytokine correlated only with ToM bias and only in delusional patients, elevated levels of this cytokine in the blood may eventually serve as a useful biomarker distinguishing delusional patients from both non-delusional patients and healthy controls.


Subject(s)
Biomarkers/blood , Psychotic Disorders/diagnosis , Psychotic Disorders/immunology , Schizophrenia/diagnosis , Schizophrenia/immunology , Schizophrenic Psychology , ADAM Proteins/blood , Adult , Chemokine CCL22/blood , Cohort Studies , Delusions/diagnosis , Delusions/immunology , Delusions/psychology , Female , Humans , Interleukin-10/blood , Male , Middle Aged , Psychiatric Status Rating Scales , Psychotic Disorders/psychology , Tumor Suppressor Proteins/blood
2.
Br J Psychiatry ; 189: 182-3, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16880491

ABSTRACT

Voltage-gated potassium channel antibody encephalopathy, a rare cause of limbic encephalopathy, typically presents with memory impairment and seizures. Psychiatric symptoms have not been emphasised in the literature. Here we describe a 58-year-old man who presented with panic attacks and psychogenic non-epileptic seizures and, later on, developed delusions and hallucinations and then confusion. He was found to have antibodies to voltage-gated potassium channels. Treatment with immuno-modulatory therapy resulted in almost complete recovery.


Subject(s)
Antibodies/analysis , Brain Diseases/psychology , Panic Disorder/immunology , Potassium Channels, Voltage-Gated/immunology , Brain Diseases/immunology , Confusion/immunology , Confusion/psychology , Confusion/therapy , Delusions/immunology , Delusions/psychology , Delusions/therapy , Hallucinations/immunology , Hallucinations/psychology , Hallucinations/therapy , Humans , Male , Middle Aged , Panic Disorder/psychology , Panic Disorder/therapy , Seizures/immunology , Seizures/psychology , Seizures/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL